Mukherjee D - Search Results

1

Endovascular therapy for acute ischaemic stroke: a systematic review and meta-analysis of randomized trials.

Sardar P, Chatterjee S, Giri J, Kundu A, Tandar A, Sen P, Nairooz R, Huston J, Ryan JJ, Bashir R, Parikh SA, White CJ, Meyers PM, Mukherjee D, Majersik JJ, Gray WA. Sardar P, et al. Among authors: mukherjee d. Eur Heart J. 2015 Sep 14;36(35):2373-80. doi: 10.1093/eurheartj/ehv270. Epub 2015 Jun 12. Eur Heart J. 2015. PMID: 26071599 Review.

2

Platelet glycoprotein IIb/IIIa inhibition in acute coronary syndromes. Gradient of benefit related to the revascularization strategy.

Roffi M, Chew DP, Mukherjee D, Bhatt DL, White JA, Moliterno DJ, Heeschen C, Hamm CW, Robbins MA, Kleiman NS, Théroux P, White HD, Topol EJ. Roffi M, et al. Among authors: mukherjee d. Eur Heart J. 2002 Sep;23(18):1441-8. doi: 10.1053/euhj.2002.3160. Eur Heart J. 2002. PMID: 12208224

3

Carotid artery stenting vs. endarterectomy.

Roffi M, Mukherjee D, Clair DG. Roffi M, et al. Among authors: mukherjee d. Eur Heart J. 2009 Nov;30(22):2693-704. doi: 10.1093/eurheartj/ehp471. Epub 2009 Oct 27. Eur Heart J. 2009. PMID: 19861324 Review.

4

Steroids for the prevention of restenosis in bare-metal stents--a systematic review and meta-analysis.

Sardar P, Chatterjee S, Mukherjee D, Garratt KN. Sardar P, et al. Among authors: mukherjee d. J Invasive Cardiol. 2012 Mar;24(3):98-103. J Invasive Cardiol. 2012. PMID: 22388299 Free article. Review.

5

Catheter ablation for atrial fibrillation.

Porres-Aguilar M, Chatterjee S, Mukherjee D. Porres-Aguilar M, et al. Among authors: mukherjee d. N Engl J Med. 2012 Mar 15;366(11):1059-60; author reply 1060-1. doi: 10.1056/NEJMc1200491. N Engl J Med. 2012. PMID: 22417266 No abstract available.

6

Meta-analysis of cardiovascular outcomes with dronedarone in patients with atrial fibrillation or heart failure.

Chatterjee S, Ghosh J, Lichstein E, Aikat S, Mukherjee D. Chatterjee S, et al. Among authors: mukherjee d. Am J Cardiol. 2012 Aug 15;110(4):607-13. doi: 10.1016/j.amjcard.2012.04.034. Epub 2012 May 19. Am J Cardiol. 2012. PMID: 22608952

7

PAR-1 antagonists: current state of evidence.

Chatterjee S, Sharma A, Mukherjee D. Chatterjee S, et al. Among authors: mukherjee d. J Thromb Thrombolysis. 2013 Jan;35(1):1-9. doi: 10.1007/s11239-012-0752-4. J Thromb Thrombolysis. 2013. PMID: 22644721 Review.

8

Intensive glucose control in diabetics with an acute myocardial infarction does not improve mortality and increases risk of hypoglycemia-a meta-regression analysis.

Chatterjee S, Sharma A, Lichstein E, Mukherjee D. Chatterjee S, et al. Among authors: mukherjee d. Curr Vasc Pharmacol. 2013 Jan;11(1):100-4. Curr Vasc Pharmacol. 2013. PMID: 22724474 Clinical Trial.

9

Eplerenone is not superior to older and less expensive aldosterone antagonists.

Chatterjee S, Moeller C, Shah N, Bolorunduro O, Lichstein E, Moskovits N, Mukherjee D. Chatterjee S, et al. Among authors: mukherjee d. Am J Med. 2012 Aug;125(8):817-25. doi: 10.1016/j.amjmed.2011.12.018. Am J Med. 2012. PMID: 22840667 Review.

10

Extended thromboprophylaxis for medically ill patients with decreased mobility: does it improve outcomes?

Sharma A, Chatterjee S, Lichstein E, Mukherjee D. Sharma A, et al. Among authors: mukherjee d. J Thromb Haemost. 2012 Oct;10(10):2053-60. doi: 10.1111/j.1538-7836.2012.04874.x. J Thromb Haemost. 2012. PMID: 22863355 Free article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

2,112 results

Search Page